{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:41:38Z","timestamp":1783478498625,"version":"3.55.0"},"reference-count":47,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej20-0478","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T22:05:41Z","timestamp":1600898741000},"page":"989-995","source":"Crossref","is-referenced-by-count":19,"title":["The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma"],"prefix":"10.1507","volume":"67","author":[{"given":"Kenji","family":"Oki","sequence":"first","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso E.","family":"Gomez-Sanchez","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, G.V. (Sonny) Montgomery VA Medical Center and Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101: 1889\u20131916.","DOI":"10.1210\/jc.2015-4061"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Choi M, Scholl UI, Yue P, Bj\u00f6rklund P, Zhao B, et al. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331: 768\u2013772.","DOI":"10.1126\/science.1198785"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, et al. (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45: 1055\u20131060.","DOI":"10.1038\/ng.2716"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, et al. (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45: 440\u2013444, 444e1\u20132.","DOI":"10.1038\/ng.2550"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Akerstrom T, Maharjan R, Sven Willenberg H, Cupisti K, Ip J, et al. (2016) Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci Rep 6: 19546.","DOI":"10.1038\/srep19546"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Dutta RK, Arnesen T, Heie A, Walz M, Alesina P, et al. (2019) A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma. Eur J Endocrinol 181: K37\u2013K41.","DOI":"10.1530\/EJE-19-0377"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 De Sousa K, Boulkroun S, Baron S, Nanba K, Wack M, et al. (2020) Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma. Hypertension 75: 1034\u20131044.","DOI":"10.1161\/HYPERTENSIONAHA.119.14177"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, et al. (2014) Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 383: 111\u2013117.","DOI":"10.1016\/j.mce.2013.11.022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Scholl UI, Stolting G, Schewe J, Thiel A, Tan H, et al. (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50: 349\u2013354.","DOI":"10.1038\/s41588-018-0048-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fernandes-Rosa FL, Daniil G, Orozco IJ, Goppner C, El Zein R, et al. (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 50: 355\u2013361.","DOI":"10.1038\/s41588-018-0053-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Scholl UI, Stolting G, Nelson-Williams C, Vichot AA, Choi M, et al. (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 4: e06315.","DOI":"10.7554\/eLife.06315.019"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE (2012) Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 153: 1774\u20131782.","DOI":"10.1210\/en.2011-1733"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Bassett MH, Mayhew B, Rehman K, White PC, Mantero F, et al. (2005) Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab 90: 5446\u20135455.","DOI":"10.1210\/jc.2005-0836"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Williams TA, Monticone S, Morello F, Liew CC, Mengozzi G, et al. (2010) Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis <i>in vitro<\/i>. Hypertension 55: 1468\u20131475.","DOI":"10.1161\/HYPERTENSIONAHA.110.150318"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Swierczynska MM, Betz MJ, Colombi M, Dazert E, Jeno P, et al. (2019) Proteomic landscape of aldosterone-producing adenoma. Hypertension 73: 469\u2013480.","DOI":"10.1161\/HYPERTENSIONAHA.118.11733"},{"key":"16","unstructured":"16 Ono Y, Yamazaki Y, Omata K, Else T, Tomlins SA, et al. (2020) Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations. J Clin Endocrinol Metab 105: e282\u2013e289."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, et al. (2015) Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol Cell Endocrinol 411: 146\u2013154.","DOI":"10.1016\/j.mce.2015.04.022"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Seccia TM, Caroccia B, Gomez-Sanchez EP, Gomez-Sanchez CE, Rossi GP (2018) The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications. Endocr Rev 39: 1029\u20131056.","DOI":"10.1210\/er.2018-00060"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Itcho K, Oki K, Gomez-Sanchez CE, Gomez-Sanchez EP, Ohno H, et al. (2020) Endoplasmic reticulum chaperone calmegin is upregulated in aldosterone-producing adenoma and associates with aldosterone production. Hypertension 75: 492\u2013499.","DOI":"10.1161\/HYPERTENSIONAHA.119.14062"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Sasano H, Mason JI, Sasano N (1989) Immunohistochemical study of cytochrome P-45017 alpha in human adrenocortical disorders. Hum Pathol 20: 113\u2013117.","DOI":"10.1016\/0046-8177(89)90174-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Fallo F, Pezzi V, Barzon L, Mulatero P, Veglio F, et al. (2002) Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur J Endocrinol 147: 795\u2013802.","DOI":"10.1530\/eje.0.1470795"},{"key":"22","unstructured":"22 Azizan EA, Lam BY, Newhouse SJ, Zhou J, Kuc RE, et al. (2012) Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J Clin Endocrinol Metab 97: E819\u2013E829."},{"key":"23","doi-asserted-by":"publisher","unstructured":"23 Yoshii Y, Oki K, Gomez-Sanchez CE, Ohno H, Itcho K, et al. (2016) Hypomethylation of CYP11B2 in aldosterone-producing adenoma. Hypertension 68: 1432\u20131437.","DOI":"10.1161\/HYPERTENSIONAHA.116.08313"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kobuke K, Oki K, Gomez-Sanchez CE, Gomez-Sanchez EP, Ohno H, et al. (2018) Calneuron 1 increased Ca<sup>2+<\/sup> in the endoplasmic reticulum and aldosterone production in aldosterone-producing adenoma. Hypertension 71: 125\u2013133.","DOI":"10.1161\/HYPERTENSIONAHA.117.10205"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25 Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, et al. (2012) Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59: 592\u2013598.","DOI":"10.1161\/HYPERTENSIONAHA.111.186478"},{"key":"26","unstructured":"26 Monticone S, Hattangady NG, Nishimoto K, Mantero F, Rubin B, et al. (2012) Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab 97: E1567\u2013E1572."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Akerstrom T, Willenberg HS, Cupisti K, Ip J, Backman S, et al. (2015) Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. Endocr Relat Cancer 22: 735\u2013744.","DOI":"10.1530\/ERC-15-0321"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE (2002) Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143: 3651\u20133657.","DOI":"10.1210\/en.2001-211359"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Assie G, Auzan C, Gasc JM, Baviera E, Balaton A, et al. (2005) Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. J Clin Endocrinol Metab 90: 6638\u20136649.","DOI":"10.1210\/jc.2005-1309"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Williams TA, Monticone S, Crudo V, Warth R, Veglio F, et al. (2012) Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 59: 833\u2013839.","DOI":"10.1161\/HYPERTENSIONAHA.111.188532"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Bittremieux M, Parys JB, Pinton P, Bultynck G (2016) ER functions of oncogenes and tumor suppressors: modulators of intracellular Ca<sup>2+<\/sup> signaling. Biochim Biophys Acta 1863: 1364\u20131378.","DOI":"10.1016\/j.bbamcr.2016.01.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Li X, Wang B, Tang L, Zhang Y, Chen L, et al. (2018) GSTA1 expression is correlated with aldosterone level in KCNJ5-mutated adrenal aldosterone-producing adenoma. J Clin Endocrinol Metab 103: 813\u2013823.","DOI":"10.1210\/jc.2017-00950"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Zhou J, Lam B, Neogi SG, Yeo GS, Azizan EA, et al. (2016) Transcriptome pathway analysis of pathological and physiological aldosterone-producing human tissues. Hypertension 68: 1424\u20131431.","DOI":"10.1161\/HYPERTENSIONAHA.116.08033"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Berthon A, Drelon C, Ragazzon B, Boulkroun S, Tissier F, et al. (2014) WNT\/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum Mol Genet 23: 889\u2013905.","DOI":"10.1093\/hmg\/ddt484"},{"key":"35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2011.01.014","volume":"144","author":"H Fujiwara","year":"2011","unstructured":"35 Fujiwara H, Ferreira M, Donati G, Marciano DK, Linton JM, et al. (2011) The basement membrane of hair follicle stem cells is a muscle cell niche. Cell 144: 577\u2013589.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36 Teo AE, Garg S, Johnson TI, Zhao W, Zhou J, et al. (2017) Physiological and pathological roles in human adrenal of the glomeruli-defining matrix protein NPNT (nephronectin). Hypertension 69: 1207\u20131216.","DOI":"10.1161\/HYPERTENSIONAHA.117.09156"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Shanak S, Helms V (2020) DNA methylation and the core pluripotency network. Dev Biol 464: 145\u2013160.","DOI":"10.1016\/j.ydbio.2020.06.001"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Rubattu S, Stanzione R, Cotugno M, Bianchi F, Marchitti S, et al. (2020) Epigenetic control of natriuretic peptides: implications for health and disease. Cell Mol Life Sci Online ahead of print.","DOI":"10.1007\/s00018-020-03573-0"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, et al. (2011) Evaluation of the infinium methylation 450K technology. Epigenomics 3: 771\u2013784.","DOI":"10.2217\/epi.11.105"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Murakami M, Yoshimoto T, Nakabayashi K, Tsuchiya K, Minami I, et al. (2015) Integration of transcriptome and methylome analysis of aldosterone-producing adenomas. Eur J Endocrinol 173: 185\u2013195.","DOI":"10.1530\/EJE-15-0148"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Howard B, Wang Y, Xekouki P, Faucz FR, Jain M, et al. (2014) Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas. J Clin Endocrinol Metab 99: E536\u2013E543.","DOI":"10.1210\/jc.2013-3495"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Itcho K, Oki K, Kobuke K, Yoshii Y, Ohno H, et al. (2018) Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma. Mol Cell Endocrinol 461: 100\u2013104.","DOI":"10.1016\/j.mce.2017.08.019"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Kobuke K, Oki K, Gomez-Sanchez CE, Ohno H, Itcho K, et al. (2018) Purkinje cell protein 4 expression is associated with DNA methylation status in aldosterone-producing adenoma. J Clin Endocrinol Metab 103: 965\u2013971.","DOI":"10.1210\/jc.2017-01996"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Felizola SJ, Nakamura Y, Ono Y, Kitamura K, Kikuchi K, et al. (2014) PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J Mol Endocrinol 52: 159\u2013167.","DOI":"10.1530\/JME-13-0248"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Peng KY, Chang HM, Lin YF, Chan CK, Chang CH, et al. (2018) miRNA-203 modulates aldosterone levels and cell proliferation by targeting Wnt5a in aldosterone-producing adenomas. J Clin Endocrinol Metab 103: 3737\u20133747.","DOI":"10.1210\/jc.2018-00746"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Decmann A, Nyiro G, Darvasi O, Turai P, Bancos I, et al. (2019) Circulating miRNA expression profiling in primary aldosteronism. Front Endocrinol (Lausanne) 10: 739.","DOI":"10.3389\/fendo.2019.00739"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Nakano Y, Yoshimoto T, Watanabe R, Murakami M, Fukuda T, et al. (2019) miRNA299 involvement in CYP11B2 expression in aldosterone-producing adenoma. Eur J Endocrinol 181: 69\u201378.","DOI":"10.1530\/EJE-18-0882"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/10\/67_EJ20-0478\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T03:31:24Z","timestamp":1604115084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/10\/67_EJ20-0478\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0478","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}